Singapore’s Travecta Therapeutics secures $15m in Series A funding

Singapore’s Travecta Therapeutics secures $15m in Series A funding

Photo: Pixabay

14 May, 2020

biopharmaceutical SPRIM Tikehau capital Travecta Therapeutics

Printed by Unregistered user on Sun, 21 Dec 2025 20:13:00 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SK Holdings leads SG's Hummingbird Bioscience's $25m Series B extension

Tikehau Capital appoints Neil Parekh as new Asia regional head

Read more from Singapore

Editor’s take: The week that was — Dec 15-20

‘Singapore washing’ gains pace as Chinese firms relocate to city-state